Skip to main content
. Author manuscript; available in PMC: 2014 May 6.
Published in final edited form as: Mol Pharm. 2013 Mar 25;10(5):2086–2090. doi: 10.1021/mp300662r

Figure 2.

Figure 2

(a) Amount of rhodamine-labeled mBMP bond to cortical bone after incubating in various conditions. Quantification of fluorescence intensity of (b) rhodamine-labeled mBMP bound to cortical bone by incubating in various conditions, and (c) rhodamine-labeled mBMP and mBMP-mut bound to cortical bone by incubating in 100 µg/mL peptide solution for different time periods. Data are shown as mean ± standard deviation. * p < 0.01 and ** p < 0.05.